Abstract:Widespread use of fluconazole for the prophylaxis and treatment of candidiasis has led to a reduction in the number of cases of candidemia caused by Candida albicans but has also resulted in the emergence of candidemias caused by innately fluconazole-resistant, non-C. albicans Candida species. Given the fulminant and rapidly fatal outcome of acute disseminated candidiasis, rapid identification of newly emerging Candida species in blood culture is critical for the implementation of appropriately targeted antifungal drug therapy. Therefore, we used a PCR-based assay to rapidly identify Candida species from positive blood culture bottles. This assay used fungus-specific, universal primers for DNA amplification and species-specific probes to identify C. albicans, C. krusei, C. parapsilosis, C. tropicalis, or C. glabrata amplicons. It also used a simpler and more rapid (1.5-h) sample preparation technique than those described previously and used detergent, heat, and mechanical breakage to recover Candida species DNA from blood cultures. A simple and rapid (3.5-h) enzyme immunosorbent assay (EIA)-based format was then used for amplicon detection. One hundred fifty blood culture bottles, including 73 positive blood culture bottle sets (aerobic and anaerobic) from 31 patients with candidemia, were tested. The combined PCR and EIA methods (PCR-EIA) correctly identified all Candida species in 73 blood culture bottle sets, including bottles containing bacteria coisolated with yeasts and 3 cultures of samples from patients with mixed candidemias originally identified as single-species infections by routine phenotypic identification methods. Species identification time was reduced from a mean of 3.5 days by routine phenotypic methods to 7 h by the PCR-EIA method. No false-positive results were obtained for patients with bacteremias (n = 18), artificially produced non-Candida fungemias (n = 3), or bottles with no growth (n = 20). Analytical sensitivity was 1 cell per 2-microl sample. This method is simpler and more rapid than previously described molecular identification methods, can identify all five of the most medically important Candida species, and has the potential to be automated for use in the clinical microbiology laboratory.

The research of rapid susceptibility testing of candida species by flow cytometry

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

Flow Cytometry:a Method of Testing the Sensitivty of Fungi to Fluconaiole

Rapid identification,fluconazole and micafungin susceptibility testing of Candida species from blood culture by a short incubation method.

Measure MICs of antibiotic by Flow cytometry

Comparative evaluation of ATB FUNGUS 2 procedure and CLSI M27-A2 broth microdilution method for antifungal susceptibility testing of Candida species and Cryptococcus neoformans

Novel automated antifungal susceptibility testing system for yeasts based on dual-detection algorithm of turbidimetry and colorimetry

Antifungal Susceptibility Testing of 100 Clinical Isolates of Pathogenic Yeasts

Application of Single-Cell Real-Time Imaging Flow Cytometry in Rapid Detection of Pathogenic Fungi in Clinical Liquid Specimens

High-Throughput Monitoring of Pathogenic Fungal Growth Using Whole Slide Imaging for Rapid Antifungal Susceptibility Assessment

Antifungal susceptibility testing in Candida species: current methods and promising new tools for shortening the turnaround time

Rapid identification of Candida species in blood cultures by a clinically useful PCR method

Comparison of four different methods in testing the in vitro susceptibility of Candida to fluconazole and voriconazole

Evaluation of three methods for testing yeasts susceptibility to fluconazole

Evaluation of fluorescence in situ hybridisation (FISH) for the identification of Candida albicans in comparison with three phenotypic methods

Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

A Rapid, Visible, and Highly Sensitive Method for Recognizing and Distinguishing Invasive Fungal Infections via CCP-FRET Technology

Modified Colorimetric Assay for Susceptibility Testing of Azole Antifungal Drugs Against Candida Species

Rapid Detection of Candida tropicalis in Clinical Samples From Different Sources Using RPA-LFS

Antifungal Susceptibility Testing of Candida Albicans Isolated from Recurrent Vulvovaginal Candidiasis

Robust Fluorometric Aptamer Assay for Direct and Rapid Detection of Clinical Isolates of Candida spec.